Bristol Aesthetics Limited - Period Ending 2020-03-31

Bristol Aesthetics Limited - Period Ending 2020-03-31


Bristol Aesthetics Limited 11185251 false 2019-04-01 2020-03-31 2020-03-31 The principal activity of the company is aesthetic procedures Digita Accounts Production Advanced 6.26.9041.0 true 11185251 2019-04-01 2020-03-31 11185251 2020-03-31 11185251 core:CurrentFinancialInstruments 2020-03-31 11185251 core:CurrentFinancialInstruments core:WithinOneYear 2020-03-31 11185251 core:OfficeEquipment 2020-03-31 11185251 core:PlantMachinery 2020-03-31 11185251 bus:SmallEntities 2019-04-01 2020-03-31 11185251 bus:AuditExemptWithAccountantsReport 2019-04-01 2020-03-31 11185251 bus:FullAccounts 2019-04-01 2020-03-31 11185251 bus:SmallCompaniesRegimeForAccounts 2019-04-01 2020-03-31 11185251 bus:RegisteredOffice 2019-04-01 2020-03-31 11185251 bus:CompanySecretaryDirector1 2019-04-01 2020-03-31 11185251 bus:Director1 2019-04-01 2020-03-31 11185251 bus:Director3 2019-04-01 2020-03-31 11185251 bus:PrivateLimitedCompanyLtd 2019-04-01 2020-03-31 11185251 core:OfficeEquipment 2019-04-01 2020-03-31 11185251 core:PlantMachinery 2019-04-01 2020-03-31 11185251 countries:AllCountries 2019-04-01 2020-03-31 11185251 2019-03-31 11185251 core:OfficeEquipment 2019-03-31 11185251 core:PlantMachinery 2019-03-31 11185251 2018-02-05 2019-03-31 11185251 2019-03-31 11185251 core:CurrentFinancialInstruments 2019-03-31 11185251 core:CurrentFinancialInstruments core:WithinOneYear 2019-03-31 11185251 core:OfficeEquipment 2019-03-31 11185251 core:PlantMachinery 2019-03-31 iso4217:GBP xbrli:pure

Registration number: 11185251

Bristol Aesthetics Limited

Unaudited Filleted Financial Statements

for the Year Ended 31 March 2020

 

Bristol Aesthetics Limited

Contents

Company Information

1

Balance Sheet

2 to 3

Notes to the Unaudited Financial Statements

4 to 8

 

Bristol Aesthetics Limited

Company Information

Directors

Mr N Mercer

Mr A Orlando

Mr A Rao

Company secretary

Mr A Orlando

Registered office

58 Queen Square
Bristol
BS1 4LF

Accountants

Stone & Co Chartered Accountants
2 Charnwood House
Marsh Road
Ashton
Bristol
BS3 2NA

 

Bristol Aesthetics Limited

(Registration number: 11185251)
Balance Sheet as at 31 March 2020

Note

2020
£

2019
£

         

Fixed assets

   

Tangible assets

4

 

25,585

30,422

Current assets

   

Stocks

5

4,549

 

4,685

Debtors

6

1,947

 

7,770

Cash at bank and in hand

 

14,859

 

37,973

 

21,355

 

50,428

Creditors: Amounts falling due within one year

7

(99,937)

 

(113,652)

Net current liabilities

   

(78,582)

(63,224)

Net liabilities

   

(52,997)

(32,802)

Capital and reserves

   

Called up share capital

100

 

100

Profit and loss account

(53,097)

 

(32,902)

Total equity

   

(52,997)

(32,802)

For the financial year ending 31 March 2020 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Profit and Loss Account has been taken.

Approved and authorised by the Board on 4 February 2021 and signed on its behalf by:
 

 

Bristol Aesthetics Limited

(Registration number: 11185251)
Balance Sheet as at 31 March 2020

.........................................
Mr N Mercer
Director

.........................................
Mr A Orlando
Company secretary and director

.........................................
Mr A Rao
Director

     
 

Bristol Aesthetics Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2020

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
58 Queen Square
Bristol
BS1 4LF

These financial statements were authorised for issue by the Board on 4 February 2021.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A - 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006.

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

 

Bristol Aesthetics Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2020

Asset class

Depreciation method and rate

Clinical equipment

Straight line over 5 or 7 years

Office equipment

25% Reducing balance

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.

The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

 

Bristol Aesthetics Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2020

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 1 (2019 - 1).

 

Bristol Aesthetics Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2020

4

Tangible assets

Clinical equipment
£

Office equipment
£

Total
£

Cost or valuation

At 1 April 2019

37,493

-

37,493

Additions

1,154

365

1,519

At 31 March 2020

38,647

365

39,012

Depreciation

At 1 April 2019

7,071

-

7,071

Charge for the year

6,295

61

6,356

At 31 March 2020

13,366

61

13,427

Carrying amount

At 31 March 2020

25,281

304

25,585

At 31 March 2019

30,422

-

30,422

5

Stocks

2020
£

2019
£

Other inventories

4,549

4,685

6

Debtors

2020
£

2019
£

Prepayments

1,331

1,170

Other debtors

616

6,600

1,947

7,770

 

Bristol Aesthetics Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2020

7

Creditors

Creditors: amounts falling due within one year

2020
£

2019
£

Due within one year

Trade creditors

287

-

Taxation and social security

1,418

-

Accruals and deferred income

1,000

1,000

Other creditors

97,232

112,652

99,937

113,652

8

Related party transactions

Other transactions with directors

The company was under the control of Mr A Orlando and Mr N Mercer throughout the majority of the current year and the entirety of the prior period.

Mr A Rao was appointed a director towards the end of the accounting period.

Mr A Orlando, Mr N Mercer and Mr A Rao are equal shareholders.

During the year Bristol Plastic Surgery LLP, of which both Mr A Orlando and Mr N Mercer are partners, received a loan from the company. As at the year end the company was owed £516 (2019: owed £760 to) by Bristol Plastic Surgery LLP which is included on other debtors with no fixed repayment terms.

During the year 58 Queen Square Limited, of which Mr A Orlando, Mr N Mercer and Mr A Rao are all directors, made loans to the company. As at the year end the company owed £97,232 (2019: £111,892) to 58 Queen Square Limited included in other creditors with no fixed repayment terms.